Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 44,130 | 34,046 | 32,644 | 20,596 | 21,309 |
| Cost of Goods | 5,367 | 4,055 | 4,344 | 4,310 | 3,135 |
| Gross Profit | 38,763 | 29,991 | 28,300 | 16,286 | 18,174 |
| Operating Expenses | 115,560 | 111,325 | 98,127 | 172,777 | 65,240 |
| Operating Income | -76,430 | -81,279 | -69,483 | -156,181 | -46,931 |
| Interest Expense | 4,625 | 6,454 | 8,639 | 4,715 | 4,560 |
| Other Income | -2,779 | -32,398 | 1,049 | 1,682 | -10,003 |
| Pre-tax Income | -83,834 | -120,131 | -77,073 | -159,214 | -61,494 |
| Income Tax | 717 | 168 | 1,010 | -51 | 339 |
| Net Income Continuous | -84,551 | -120,299 | -78,083 | -159,163 | -61,833 |
| Net Income | $-84,551 | $-120,299 | $-78,083 | $-159,163 | $-61,833 |
| EPS Basic Total Ops | -0.36 | -0.56 | -0.43 | -0.84 | -0.33 |
| EPS Basic Continuous Ops | -0.36 | -0.56 | -0.43 | -0.84 | -0.33 |
| EPS Diluted Total Ops | -0.36 | -0.56 | -0.43 | -0.84 | -0.33 |
| EPS Diluted Continuous Ops | -0.36 | -0.56 | -0.43 | -0.84 | -0.33 |
| EBITDA(a) | $-74,821 | $-78,639 | $-65,174 | $-152,513 | $-43,286 |